Next Article in Journal
Targeting in Cancer Therapies
Previous Article in Journal
Insights into Putative Health Implications of Gelam (Melaleuca cajuputi) Honey: Evidence from In-Vivo and In-Vitro Studies
Article Menu

Export Article

Open AccessArticle
Med. Sci. 2016, 4(1), 4; doi:10.3390/medsci4010004

Acute and Sub-Acute Toxicity Evaluation of the Methanolic Extract of Alstonia scholaris Stem Bark

1
Department of Pharmacology, School of Pharmaceutical Sciences, University Sains Malaysia (USM), 11800 Pulau Pinang, Malaysia
2
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, University Sains Malaysia (USM), 11800 Pulau Pinang, Malaysia
*
Author to whom correspondence should be addressed.
Academic Editor: Yu-Jia Chang
Received: 5 December 2015 / Revised: 22 February 2016 / Accepted: 1 March 2016 / Published: 8 March 2016
View Full-Text   |   Download PDF [1313 KB, uploaded 8 March 2016]   |  

Abstract

Alstonia scholaris has been used by traditional medicine practitioners since the medieval ages for the treatment of diseases. The aim of this research was to evaluate the acute and sub-acute oral toxicity of its methanolic extract. The acute toxicity test was conducted using Sprague Dawley (SD) rats. The methanolic extract of Alstonia scholaris stem bark (ASME) was administrated in a single dose of 2000 mg/kg via oral gavage; and the animals were observed for any behavioral changes or mortality. In the sub-acute toxicity study, SD rats received three doses of ASME (250, 500 and 1000 mg/kg) for 28 days via oral gavage. During these 28 days of treatment, the rats were observed weekly for toxicity symptoms. Following the 28-day treatment, the rats were sacrificed for hematological, biochemical and histopathology studies. In the acute toxicity study, Alstonia scholaris was found to be non-toxic at a dose of 2000 mg/kg b.w. In the sub-acute toxicity study, significant variations in body weight, hematological and biochemical parameters were observed in the experimental groups at the dose of 500 and 1000 mg/kg with the death of two female rats being recorded at the highest dose (1000 mg/kg b.w.). Histopathological studies revealed slight degeneration (lesion) and centrilobular necrosis in the liver, which was most expressed in the highest-dose group. These results demonstrate that, while a single dose and short term oral intake of Alstonia scholaris bark extract caused no toxicity up to a dose of 2000 mg/kg b.w., toxic effects manifested in the long term treatment at the highest dose (500 and 1000 mg/kg). The long-term toxic effect was found to be associated with alterations in hematological compositions and end-organ damage to the liver. Thus, prolonged use of high doses of ASME orally should be discouraged and lower doses encouraged. View Full-Text
Keywords: acute; Alstonia scholaris; sub-acute; toxicity; herb; plant; extract acute; Alstonia scholaris; sub-acute; toxicity; herb; plant; extract
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Bello, I.; Bakkouri, A.S.; Tabana, Y.M.; Al-Hindi, B.; Al-Mansoub, M.A.; Mahmud, R.; Asmawi, M.Z. Acute and Sub-Acute Toxicity Evaluation of the Methanolic Extract of Alstonia scholaris Stem Bark. Med. Sci. 2016, 4, 4.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Med. Sci. EISSN 2076-3271 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top